GPC3 and hepatocellular carcinoma: Furthermore, serum GPC3 is commonly increased in HCC due to cell surface GPC3 shedding, and shed GPC3 (sGPC3) is a negative regulator of cell surface GPC3 leading to inhibition of HCC cell growth [21,22], and blocking anti-GPC3 CAR T cells binding, reducing treatment efficacy [23].